GENFIT S.A - Stock Price History | GNFT

Historical daily share price chart and data for GENFIT S.A since 2021 adjusted for splits. The latest closing stock price for GENFIT S.A as of September 27, 2021 is 3.85.
  • The all-time high GENFIT S.A stock closing price was 25.65 on April 08, 2019.
  • The GENFIT S.A 52-week high stock price is 7.19, which is 86.8% above the current share price.
  • The GENFIT S.A 52-week low stock price is 3.50, which is 9.1% below the current share price.
  • The average GENFIT S.A stock price for the last 52 weeks is 4.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
GENFIT S.A Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 9.5556 20.6600 22.0000 3.6300 4.8000 -75.88%
2019 18.8747 22.1700 25.6500 13.5500 19.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.176B $0.009B
Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29